PD-L1 is an immuno-suppressive molecule that binds to the PD-1 receptor on the surface of T cells, inhibiting the activity of T cells and leading to tumor immune escape (Daassi et al., 2020; Kornepati et al., 2022). This evidence concerns the gene CD274 and neoplasm.